Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Verve Therapeutics stock

Learn how to easily invest in Verve Therapeutics stock.

Verve Therapeutics Inc is a biotechnology business based in the US. Verve Therapeutics shares (VERV) are listed on the NASDAQ and all prices are listed in US Dollars. Verve Therapeutics employs 113 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Verve Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VERV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Verve Therapeutics stock price (NASDAQ: VERV)

Use our graph to track the performance of VERV stocks over time.

Verve Therapeutics shares at a glance

Information last updated 2022-06-25.
Latest market close$15.50
52-week range$10.70 - $78.00
50-day moving average $14.69
200-day moving average $31.33
Wall St. target price$53.83
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.58

Buy Verve Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
Financial advice powered by relationships, not commissions.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Verve Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Verve Therapeutics price performance over time

Historical closes compared with the close of $15.5 from 2022-06-29

1 week (2022-06-24) -8.28%
1 month (2022-06-01) 7.34%
3 months (2022-04-01) -31.14%
6 months (2021-12-31) -57.96%
1 year (2021-07-01) -70.83%
2 years (2020-06-27) N/A
3 years (2019-06-27) N/A
5 years (2017-06-27) N/A

Verve Therapeutics financials

Gross profit TTM $0
Return on assets TTM -25.85%
Return on equity TTM -57.91%
Profit margin 0%
Book value $6.81
Market capitalisation $822.4 million

TTM: trailing 12 months

Verve Therapeutics share dividends

We're not expecting Verve Therapeutics to pay a dividend over the next 12 months.

Verve Therapeutics overview

Verve Therapeutics, Inc. , a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc. ; a development and option agreement with Acuitas Therapeutics, Inc. ; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College.

Frequently asked questions

What percentage of Verve Therapeutics is owned by insiders or institutions?
Currently 35.389% of Verve Therapeutics shares are held by insiders and 80.071% by institutions.
How many people work for Verve Therapeutics?
Latest data suggests 113 work at Verve Therapeutics.
When does the fiscal year end for Verve Therapeutics?
Verve Therapeutics's fiscal year ends in December.
Where is Verve Therapeutics based?
Verve Therapeutics's address is: 500 Technology Square, Cambridge, MA, United States, 02139
What is Verve Therapeutics's ISIN number?
Verve Therapeutics's international securities identification number is: US92539P1012

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site